Listen and follow our podcasts on:

Eisai Europe

Listen to the podcast

 

In this educational podcast, Veerle Lamotte and Paola Belardi share their successful experience of managing patients treated with VEGFR-TKIs for select solid tumours.

The short 15-minute discussion captures and provides you with their useful insight on:

1. The safety profile of VEGFR-TKIs alone or in combination with PD-1 inhibitors in hepatocellular cancer (HCC), differentiated thyroid cancer (DTC) & advanced renal cell carcinoma (RCC) and how to recognise side effects & understand appropriate management

2. How to best manage patients both prior to & during treatment to ensure optimal treatment success, including prehabilitation of patients prior to treatment & management of side effects on treatment

Veerle and Paola have many years nursing experience and present views not only from the perspective of the nurse, but also with relevance across geographies.

This is the first collaboration between GI NURSES CONNECT and GU NURSES CONNECT on an educational programme offering a valuable resource that is not limited to one tumour type.

This GI NURSES CONNECT and GU NURSES CONNECT podcast is also available on
Castos, Spotify, Apple Podcasts, and Google Podcasts.

Veerle Lamotte has worked as an oncology nurse practitioner at Antwerp University Hospital since 2013. She graduated as a nurse in 2001, working initially in intensive care before moving to work in oncology in 2010. Veerle supports and guides patients within the tumour cluster uro-oncology care process; from diagnosis, during treatment, follow-up phase and at relapse.  As an oncology nurse she has detailed knowledge and experience of urology, oncology and palliative care. Veerle is also a board member of UROBEL (the Belgian National Association for Urological Nurses) which keep nurses in Belgium informed about new strategies in uro-oncological healthcare. 

Veerle Lamotte has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Ipsen and Pfizer. 

Paola Belardi is a Nurse Co-ordinator at San Donato Hospital in Arezzo, Italy. Paola gained her first level Nursing Degree at the University of Siena in 2000. Later, in 2002 she attended a Public Health class at the University of Florence and in 2010 she graduated the Master Degree in Management at the University of Siena. In 2013 she started her work in oncology setting and now she is principally committed in activities such as nurse staffing and quality standard in oncology. From 2018 she is also an adjunct professor teaching Oncology Nursing at the University of Siena. Her professional interests are: chemotherapy and target therapy side effects management, intravenous devices management and nurses education. In the last month she has been co-supervisor of two Nursing Degree thesis: one studying the nurses’ role in fatigue prevention and the other regarding the nurses’ level of knowledge about simultaneous care model.

Listen and follow our podcasts on:

Eisai Europe

Listen to the podcast

 

In this educational podcast, Veerle Lamotte and Paola Belardi share their successful experience of managing patients treated with VEGFR-TKIs for select solid tumours.

The short 15-minute discussion captures and provides you with their useful insight on:

1. The safety profile of VEGFR-TKIs alone or in combination with PD-1 inhibitors in hepatocellular cancer (HCC), differentiated thyroid cancer (DTC) & advanced renal cell carcinoma (RCC) and how to recognise side effects & understand appropriate management

2. How to best manage patients both prior to & during treatment to ensure optimal treatment success, including prehabilitation of patients prior to treatment & management of side effects on treatment

Veerle and Paola have many years nursing experience and present views not only from the perspective of the nurse, but also with relevance across geographies.

This is the first collaboration between GI NURSES CONNECT and GU NURSES CONNECT on an educational programme offering a valuable resource that is not limited to one tumour type.

This GI NURSES CONNECT and GU NURSES CONNECT podcast is also available on
Castos, Spotify, Apple Podcasts, and Google Podcasts.

Veerle Lamotte has worked as an oncology nurse practitioner at Antwerp University Hospital since 2013. She graduated as a nurse in 2001, working initially in intensive care before moving to work in oncology in 2010. Veerle supports and guides patients within the tumour cluster uro-oncology care process; from diagnosis, during treatment, follow-up phase and at relapse.  As an oncology nurse she has detailed knowledge and experience of urology, oncology and palliative care. Veerle is also a board member of UROBEL (the Belgian National Association for Urological Nurses) which keep nurses in Belgium informed about new strategies in uro-oncological healthcare. 

Veerle Lamotte has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Ipsen and Pfizer. 

Paola Belardi is a Nurse Co-ordinator at San Donato Hospital in Arezzo, Italy. Paola gained her first level Nursing Degree at the University of Siena in 2000. Later, in 2002 she attended a Public Health class at the University of Florence and in 2010 she graduated the Master Degree in Management at the University of Siena. In 2013 she started her work in oncology setting and now she is principally committed in activities such as nurse staffing and quality standard in oncology. From 2018 she is also an adjunct professor teaching Oncology Nursing at the University of Siena. Her professional interests are: chemotherapy and target therapy side effects management, intravenous devices management and nurses education. In the last month she has been co-supervisor of two Nursing Degree thesis: one studying the nurses’ role in fatigue prevention and the other regarding the nurses’ level of knowledge about simultaneous care model.

Programme summary
  • clock Duration 15 MIN
  • clock Language(s) flag
Listen to the podcast now
Share this programme
This educational programme is supported by an Independent Educational Grant from Eisai Europe
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Eisai Europe
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GU NURSES CONNECT

GU NURSES CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer, and Eisai Europe Limited.

Meet the experts Independent IME approved
Programme summary
  • clock Duration MIN
  • clock Language(s) flag
Listen to the podcast now
Share this programme
This educational programme is supported by an Independent Educational Grant from Eisai Europe
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Eisai Europe
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GU NURSES CONNECT

GU NURSES CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer, and Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

video Video
Oncology 
ADCs in HR+/HER2- metastatic breast cancer

Optimising treatment strategies and AE management

Experts
Dr Barbara Pistilli
Endorsed by
GRASP
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock MIN
  • calendar May 2025

Educational programme supported by an Independent Educational Grant from AstraZeneca.
podcast Podcast

Episode

2

of 2

episode
Oncology 
The HER2 diagnostic and treatment landscape in NSCLC: Episode 2

Navigating common treatment scenarios in HER2-mutant non-small cell lung cancer

Experts
Dr Eric Singhi, Dr Isabel Preeshagul, Oncology Brothers (Moderators)
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock 18 MIN
  • calendar Apr 2025

Educational programme supported by an Independent Educational Grant from Bayer.
publication Publication
Oncology 
Emerging molecular testing paradigms in NSCLC management

Experts
Prof. Frédérique Penault-Llorca, Prof. Mark Socinski
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Apr 2025

Educational programme supported by an Independent Educational Grant from Bayer.
animated-video Animated Video
Oncology 
Elacestrant in ER+/HER2- metastatic breast cancer with ESR1-mut tumors

An overview of the EMERALD subgroup analyses

Experts
Prof. Javier Cortés
  • download Downloadable
    Resources
  • clock 8 MIN
  • calendar Apr 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
podcast Podcast

Episode

1

of 2

episode
Oncology 
The HER2 diagnostic and treatment landscape in NSCLC: Episode 1

A medical oncologist and a pathologist share their perspectives on best practices in identifying HER2-directed NSCLC

Experts
Prof. Fernando López-Ríos, MD, PhD, Dr Devika Das, Oncology Brothers (Moderators)
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Apr 2025

Educational programme supported by an Independent Educational Grant from Bayer.
publication Publication
Oncology 
Survey on the evolving role of the oncology nurse in the USA

Survey findings presented at ONS 2025 and published in the journal Healthcare

Experts
Nina Grenon, Natasha Pinheiro, Karen Waldrop, Brittni Prosdocimo
  • download Downloadable
    Resources
  • clock 7 MIN
  • calendar Apr 2025

Educational programme supported by an Independent Educational Grant from Bayer.